Faron, etusivu

Tiedotteet ja julkaisut

Faron Pharmaceuticals julkistaa tiedotteensa englannin kielellä.

Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results

Regulatory

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Shareholder announcement Regulatory

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Shareholder announcement Regulatory

Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds

Regulatory

Inside Information: Faron announces encouraging first overall survival data from frontline higher-risk (HR) MDS patients in the BEXMAB phase 1/2 trial

Regulatory

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Shareholder announcement Regulatory

Faron Provides Update on Investigator-Initiated Trial Portfolio for Bexmarilimab

Faron Pharmaceuticals Ltd: Grant of Options

Insider Transaction Regulatory

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Shareholder announcement Regulatory

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Shareholder announcement Regulatory
Next
Siirry takaisin sivun alkuun